Financial Services

  Dr. Robert Califf, a cardiologist who has spent most of his career at Duke University, was confirmed by the Senate on February 24, 2016, to be the next FDA commissioner, following President Barack Obama’s nomination in September 2015. 

  Heavily regulated industries, such as financial services, are often slow to adopt new technology. That’s why it’s no surprise that social media is a scary place to play for financial institutions. But, as with most things in business, if you don’t play, you can’t win. 

With the continued move towards digital securing patient data has moved to the top of the list for many healthcare organizations. I sat down with David Chou (@dchou1107) to talk about data and device privacy and security and get his perspective on the challenges and what organizations can be doing to protect themselves and their […]

  Dislike being asked for your name, account number, and password every time you call the bank? Well, times are a-changin’. Banks are turning to mobile technology for help more than ever before. Bank of America is leveraging thumbprint verification technology that enables customers to automatically be identified, as well as carry out their banking […]

  If you’ve been waiting to implement Argus Safety 8.x or upgrade your existing environment, the wait is finally over. While the new version was released last year, it takes several months to build a comprehensive validation suite, and I’m happy to announce that Perficient’s life sciences group has completed that task. On top of […]

  A few days ago, I shared a list, a much smaller list, of unicorn companies that sit in the healthcare and biotechnology industries. To refresh your memory, a unicorn is a technology-related organization with a valuation of more than $1 billion, typically a start-up, and with no real track record of success. In a recent report, […]

  Perficient’s Life Sciences practice regularly monitors the software release notes for several Oracle Health Sciences applications, as well as our own clinical and safety systems. The systems covered in our review are: 

  Have you heard? Some retail establishments, in countries like the Netherlands, don’t accept cash anymore. As I mentioned in a previous post, digital money is making big waves – everywhere. While it’s starting to make a serious dent in the United States, the use of mobile payments are much more widespread in other countries. […]

  Several days ago, I wrote about how the life sciences industry, including government organizations, is struggling when it comes to the reporting of clinical trial results to the ClinicalTrials.gov database. Unfortunately, other issues plague the industry, including one that The New York Times reported on January 14, 2016. The Government Accountability Office (GAO) found […]

  The life sciences industry could learn a little something from Southwest Airlines’ “Transfarency” campaign, in terms of reporting clinical trial results. A recent investigation by the publication STAT found significant violations in the reporting of clinical trial results to the ClinicalTrials.gov database. Most academic research institutions, drug companies, and even the National Institutes of […]

  An interesting thing happened in pharma and investing. It involved Regeneron and their July 24, 2015 FDA-approved cholesterol drug, Praluent. Forbes outlined the situation, which caused Regeneron stock to drop significantly, in a January 6, 2016 article. According to Matthew Herper, a Forbes columnist, investors got a hold of data from the FDA’s Adverse […]

  Last week, I wrote that Vice President Joe Biden was going to meet with cancer researchers to talk about regulatory questions revolving around precision medicine. Today, we know much more about the cancer “moonshot” President Obama charged Biden with in this week’s State of the Union address. In a post on the publishing platform […]